![Applying the 2005 Canadian Hypertension Education Program recommendations: 1. Diagnosis of hypertension | CMAJ Applying the 2005 Canadian Hypertension Education Program recommendations: 1. Diagnosis of hypertension | CMAJ](https://www.cmaj.ca/content/cmaj/173/5/480/F2.large.jpg)
Applying the 2005 Canadian Hypertension Education Program recommendations: 1. Diagnosis of hypertension | CMAJ
![emDOCs.net – Emergency Medicine EducationHypertensive Emergency: Pearls and Pitfalls for the ED Physician - emDOCs.net - Emergency Medicine Education emDOCs.net – Emergency Medicine EducationHypertensive Emergency: Pearls and Pitfalls for the ED Physician - emDOCs.net - Emergency Medicine Education](https://i0.wp.com/www.emdocs.net/wp-content/uploads/2019/08/thumbnail_IMG_3172.jpg?resize=568%2C751)
emDOCs.net – Emergency Medicine EducationHypertensive Emergency: Pearls and Pitfalls for the ED Physician - emDOCs.net - Emergency Medicine Education
Hippo Education | How high is too high and how should you approach asymptomatic patients in the acute setting 📈 Severely elevated BP is defined as SBP >... | Instagram
![Co-treatment with clonidine and a GRK2 inhibitor prevented rebound hypertension and endothelial dysfunction after withdrawal in diabetes | Hypertension Research Co-treatment with clonidine and a GRK2 inhibitor prevented rebound hypertension and endothelial dysfunction after withdrawal in diabetes | Hypertension Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41440-018-0016-6/MediaObjects/41440_2018_16_Fig1_HTML.jpg)
Co-treatment with clonidine and a GRK2 inhibitor prevented rebound hypertension and endothelial dysfunction after withdrawal in diabetes | Hypertension Research
![Pharmaceutics | Free Full-Text | The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights Pharmaceutics | Free Full-Text | The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-13-00714/article_deploy/html/images/pharmaceutics-13-00714-g001.png?1621029182)
Pharmaceutics | Free Full-Text | The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights
Happy DYR Friday! Let's end the week with a question you know you can answer! . . . . . . . . You got it: Clonidine is notorious for causing acute
![Frontiers | Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial Frontiers | Blood Pressure Changes Following Antihypertensive Medication Reduction, by Drug Class and Dose Chosen for Withdrawal: Exploratory Analysis of Data From the OPTiMISE Trial](https://www.frontiersin.org/files/MyHome%20Article%20Library/619088/619088_Thumb_400.jpg)